mereo biopharma 1 limited

mereo biopharma 1 limited Company Information

Share MEREO BIOPHARMA 1 LIMITED
Live 
Established

Company Number

09646998

Industry

Research and experimental development on biotechnology

 

Shareholders

mereo biopharma group plc

Group Structure

View All

Contact

Registered Address

4th floor, one cavendish place, london, W1G 0QF

mereo biopharma 1 limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MEREO BIOPHARMA 1 LIMITED at £0 based on a Turnover of £0 and 1.5x industry multiple (adjusted for size and gross margin).

mereo biopharma 1 limited Estimated Valuation

£0

Pomanda estimates the enterprise value of MEREO BIOPHARMA 1 LIMITED at £0 based on an EBITDA of £-343.8k and a 5.36x industry multiple (adjusted for size and gross margin).

mereo biopharma 1 limited Estimated Valuation

£7.9m

Pomanda estimates the enterprise value of MEREO BIOPHARMA 1 LIMITED at £7.9m based on Net Assets of £4.3m and 1.84x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Mereo Biopharma 1 Limited Overview

Mereo Biopharma 1 Limited is a live company located in london, W1G 0QF with a Companies House number of 09646998. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in June 2015, it's largest shareholder is mereo biopharma group plc with a 100% stake. Mereo Biopharma 1 Limited is a established, unknown sized company, Pomanda has estimated its turnover at £0 with unknown growth in recent years.

View Sample
View Sample
View Sample

Upgrade for unlimited company reports & a free credit check

Mereo Biopharma 1 Limited Health Check

There is insufficient data available to calculate a health check for Mereo Biopharma 1 Limited. Company Health Check FAQs

Health Check Image
Health Rating0out of 5
positive_score

0 Strong

positive_score

0 Regular

positive_score

0 Weak

size

Size

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

growth

Growth

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

production

Production

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

profitability

Profitability

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

employees

Employees

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

paystructure

Pay Structure

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

efficiency

Efficiency

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

debtordays

Debtor Days

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

creditordays

Creditor Days

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

stockdays

Stock Days

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

debtlevel

Debt Level

There is insufficient data available for this Key Performance Indicator!

- - Mereo Biopharma 1 Limited

- - Industry AVG

MEREO BIOPHARMA 1 LIMITED financials

EXPORTms excel logo

Mereo Biopharma 1 Limited's latest turnover from December 2023 is estimated at 0 and the company has net assets of £4.3 million. According to their latest financial statements, we estimate that Mereo Biopharma 1 Limited has no employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Turnover000000000
Other Income Or Grants000000000
Cost Of Sales000000000
Gross Profit000000000
Admin Expenses343,775469,718711,886413,837867,7112,552,6169,043,56610,121,4263,474,347
Operating Profit-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,121,426-3,474,347
Interest Payable0000000256,611266,876
Interest Receivable000000000
Pre-Tax Profit-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,378,037-3,741,223
Tax000000000
Profit After Tax-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,378,037-3,741,223
Dividends Paid000000000
Retained Profit-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,378,037-3,741,223
Employee Costs000000000
Number Of Employees000000000
EBITDA*-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,121,426-3,474,347

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Tangible Assets000000000
Intangible Assets4,310,7614,310,7614,310,7614,310,7614,310,7614,310,7614,310,7614,310,7614,310,761
Investments & Other000000000
Debtors (Due After 1 year)000000152,40000
Total Fixed Assets4,310,7614,310,7614,310,7614,310,7614,310,7614,310,7614,463,1614,310,7614,310,761
Stock & work in progress000000000
Trade Debtors000000000
Group Debtors000197,76500001
Misc Debtors00026,564648,4620000
Cash000000000
misc current assets00000525,5522,170,2542,102,469300,024
total current assets000224,329648,462525,5522,170,2542,102,469300,025
total assets4,310,7614,310,7614,310,7614,535,0904,959,2234,836,3136,633,4156,413,2304,610,786
Bank overdraft000000000
Bank loan000000000
Trade Creditors 000000000
Group/Directors Accounts0000004,811,12300
other short term finances000000000
hp & lease commitments000000000
other current liabilities000000000
total current liabilities0000004,811,12300
loans000000008,211,558
hp & lease commitments000000000
Accruals and Deferred Income000051,9540135,08200
other liabilities000000000
provisions000000000
total long term liabilities000051,95493,518135,08208,211,558
total liabilities000051,95493,5184,946,20508,211,558
net assets4,310,7614,310,7614,310,7614,535,0904,907,2694,742,7951,687,2106,413,230-3,600,772
total shareholders funds4,310,7614,310,7614,310,7614,535,0904,907,2694,742,7951,687,2106,413,230-3,600,772
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015
Operating Activities
Operating Profit-343,775-469,718-711,886-413,837-867,711-2,552,616-9,043,566-10,121,426-3,474,347
Depreciation000000000
Amortisation000000000
Tax000000000
Stock000000000
Debtors00-224,329-424,133648,462-152,400152,400-11
Creditors000000000
Accruals and Deferred Income000-51,95451,954-135,082135,08200
Deferred Taxes & Provisions000000000
Cash flow from operations-343,775-469,718-487,557-41,658-1,464,219-2,535,298-9,060,884-10,121,425-3,474,348
Investing Activities
capital expenditure00000000-4,310,761
Change in Investments000000000
cash flow from investments00000000-4,310,761
Financing Activities
Bank loans000000000
Group/Directors Accounts00000-4,811,1234,811,12300
Other Short Term Loans 000000000
Long term loans0000000-8,211,5588,211,558
Hire Purchase and Lease Commitments000000000
other long term liabilities000000000
share issue343,775469,718487,55741,6581,032,1855,608,2014,317,54620,392,039140,451
interest0000000-256,611-266,876
cash flow from financing343,775469,718487,55741,6581,032,185797,0789,128,66911,923,8708,085,133
cash and cash equivalents
cash000000000
overdraft000000000
change in cash000000000

mereo biopharma 1 limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for mereo biopharma 1 limited. Get real-time insights into mereo biopharma 1 limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Mereo Biopharma 1 Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for mereo biopharma 1 limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other established companies, companies in W1G area or any other competitors across 12 key performance metrics.

mereo biopharma 1 limited Ownership

MEREO BIOPHARMA 1 LIMITED group structure

Mereo Biopharma 1 Limited has no subsidiary companies.

Ultimate parent company

1 parent

MEREO BIOPHARMA 1 LIMITED

09646998

MEREO BIOPHARMA 1 LIMITED Shareholders

mereo biopharma group plc 100%

mereo biopharma 1 limited directors

Mereo Biopharma 1 Limited currently has 3 directors. The longest serving directors include Dr Denise Scots-Knight (Jun 2015) and Mr Charles Sermon (Jun 2015).

officercountryagestartendrole
Dr Denise Scots-KnightEngland65 years Jun 2015- Director
Mr Charles SermonEngland55 years Jun 2015- Director
Ms Christine FoxUnited Kingdom44 years Jan 2021- Director

P&L

December 2023

turnover

0

0%

operating profit

-343.8k

0%

gross margin

0%

0%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

4.3m

0%

total assets

4.3m

0%

cash

0

0%

net assets

Total assets minus all liabilities

mereo biopharma 1 limited company details

company number

09646998

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

June 2015

age

10

incorporated

UK

ultimate parent company

accounts

Small Company

last accounts submitted

December 2023

previous names

N/A

accountant

-

auditor

-

address

4th floor, one cavendish place, london, W1G 0QF

Bank

-

Legal Advisor

-

mereo biopharma 1 limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 2 charges/mortgages relating to mereo biopharma 1 limited. Currently there are 0 open charges and 2 have been satisfied in the past.

mereo biopharma 1 limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for MEREO BIOPHARMA 1 LIMITED. This can take several minutes, an email will notify you when this has completed.

mereo biopharma 1 limited Companies House Filings - See Documents

datedescriptionview/download